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ABSTRACT 
Premenstrual Syndrome (PMS) refers to a complex of cyclical and recurrent physical, emotional and 
behavioral symptoms that occur specifically in luteal phase and remain for minimum three consecutive 
menstrual cycles. Up to 80% of women of child bearing age report with few mild symptoms of PMS prior to 
menstruation. But clinically significant PMS is seen only in 3 to 8% of women. Its more severe form, 
Premenstrual Dysphoric Disorder (PMDD) has listed one among the Depressive mental disorders by 
American Psychiatric Association. Premenstrual Syndrome, an often neglecting medical condition due to 
social taboo of not discussing the issue of menstruation, was not considered as a disease earlier due to 
unawareness of the grave symptoms of the disease. Till now, the disease is a medical mystery with 
unknown cause and without any specific proved diagnosis and medication in modern medicine. This article 
is merely an attempt to relate PMS with Pittavritta Vyana Vata, which is an Avaranajanya Vyadhi. In 
Rituvyateetakala which is compared mainly with the luteal phase, there is Pittakopavastha and 
Vatasanchayavastha. With excess intake of Pittakar Nidan in Rituvyateetakala, Sanchita Vata specifically 
Vyana Vayu gets Avritta with Kupita Pitta and manifested in the form of Sarvanga Daha, Santapa, Klama etc. 
So the disease PMS can be managed and treated on the line of Pittavritta Vyana Vayu so as to provide relief 
from its deleterious effects and improve her family and social life. 
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INTRODUCTION
PMS is a recurrent and cyclical condition which is 
characterized by physical, psychological and behavioral 
changes of sufficient severity which result in deterioration 
of interpersonal relationships and normal activity. These 
group of symptoms often occur in luteal phase i.e. 7 to 10 
days prior to menstruation and disappears when 
menstruation starts. PMS is a complex health concern. A lot 
of reproductive age women suffer from this syndrome. In 
modern era, women work throughout the month, no 
matter what. These multitasking modern women have 
learnt to ignore their natural rhythm, which causes 
hormonal swings leading to wide range of imbalances and 
complaints. PMS, which is termed as premenstrual 
syndrome, is one among these imbalances. It is just an 
abnormal response to normal hormonal changes. 
Untreated Premenstrual disorders can lead to modest 
increase in direct costs associated with increased medical 
visits and laboratory tests and large increase in indirect 
costs through lower work productivity[1]. The diagnosis of 
PMS can also become difficult because many medical and 
psychological conditions can mimic or worsen symptoms 
of PMS[2]. Further fate is that there is no proven medicine 
till date for this syndrome in Modern Medicine. Ayurvedic 
line of treatment defends a good deal on the stage of 
disease. It is considered not only a system of Medicine 
rather it is the way of life. Now Ayurveda is becoming 
more and more acceptable globally as it is eco-friendly 
with its holistic approach. It permits to treat the disease 
without nomenclature by judging the involvement of 
Dosha Dushya only[3]. This article is an attempt to 
understand the concept of PMS with Avaranajanita Vyadhi, 
Pittavritta Vyana Vayu in Ayurveda and devising 
appropriate measures to counter this menacing problem.  
MATERIAL AND METHODS 
1) Modern literature from books as well as websites 
related to PMS. 
2) Ayurvedic Samhitas and other literature related to 
Avarana and Vatavyadhi. 
3) Research Papers related to PMS. 
Etiology 
The definite cause of PMS which is also known as 
premenstrual tension (PMT)[4], is unknown. Many theories 
have been postulated to explain the cause of PMS. 
According to some disapproved older theories, the causes 
of PMS are thought to be estrogen excess, estrogen 
withdrawal, progesterone deficiency, pyridoxine or vit. B6 
deficiency[5], alteration of glucose metabolism and fluid 
electrolyte imbalances. 
Some current theories which explain PMS causes include- 
A) Low endorphins in blood- Endorphins are feel good 
hormones, which contribute to the feeling of happiness 
and regulates mood. The level of this ‘feel good’ hormone 
drops during luteal phase of menstrual cycle. So it is 
possible that low beta endorphins lead to PMS 
symptoms[6].  
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B) Serotonin deficiency- Serotonin is a chemical in brain 
that regulates many functions including mood and 
sensitivity to pain. In support of this theory, a role of 
serotonin in the pathophysiology of PMDD has been 
consistently shown in the research investigations using 
several experimental models. During the premenstrual 
phase, patients with PMDD have lower whole blood 
serotonin level[7] and lower platelet serotonin uptake[8] 
than controls without PMDD.  
C) Nutritional cause- Magnesium and calcium deficiency 
have also been postulated as the cause of PMS because 
supplementation with these minerals have been shown to 
improve some PMS symptoms[9]. 
D) Prostaglandins- Acc. to another theory, Prostaglandin 
which is an inflammatory substance, is produced in the 
areas where PMS symptoms originates like in breast, 
brain, reproductive tract, kidney and gastrointestinal tract, 
which may play a role in symptoms like cramping, breast 
tenderness, constipation or diarrhea[10]. 
E) One theories under research include alteration in 
gamma-aminobutyric acid i.e. GABA system and hypo-
prolactinemia.[11-13] 
A genetic component has also been raised by some 
researchers.  
Besides its etiology, there are some risk factors which have 
been identified to cause PMS. These are. 
Smoking[14]- According to a research, women who smoke 
cigarettes are likely to have more than twice as more 
severe PMS symptoms than non smoker women. 
Obesity[15]- Research reveals that women with Body mass 
index (BMI) of 30 or above are nearly three times as likely 
to have PMS than women who are not obese. 
Dietary factors- Frequent consumption of fast food and 
excessive coffee intake.[16] 
 Other than these, Stress, Advanced age, History of 
depression and Positive family history of PMS has also 
mentioned in texts as risk factor for PMS. 
Epidemiology 
Premenstrual Dysphoric disorder (PMDD), as 
defined by the American Psychiatric Association (APA) 
Diagnostic and Statistical Manual, Fifth Edition (DSM-5), 
can be differentiated from premenstrual syndrome (PMS) 
by the presence of at least one affective symptom, such as 
mood swings, irritability and/or depression[17]. Symptoms 
of mild PMS have been reported to affect as many as 75% 
of women with no menstrual irregularity[18]. Clinically 
significant PMS occurs in 3 to 8% of women[19] while 
approximately 2% are affected severely, with PMDD.  
Clinical Manifestations 
 Most of the women in their reproductive age, 
suffer from mild physical and/or psychological symptoms 
just two or three days prior to the onset of menstruation. 
These symptoms which do not cause functional 
impairment or severe distress to her, should not 
considered as Premenstrual syndrome (PMS)[20]. PMS is 
defined by American College of Obstetricians and 
Gynecologists (ACOG) as at least one symptom associated 
with “economic or social dysfunction” that occurs during 
the five days before the menstruation onset and should 
remain for minimum three consecutive menstrual cycles 
Women suffering from PMS may experience 
symptoms of varying duration and severity from cycle to 
cycle. Common physical signs and symptoms include. 
Cramps 
Constipation or diarrhoea 
weight gain 
Bloating  
Fatigue 
Sleep disturbances 
Breast tenderness 
Acne 
Change in appetite with overeating and cravings for food 
Frequent psychological symptoms of PMS are- 
Anger and irritability 
Depression 
Anxiety 
Crying and oversensitivity 
Exaggerated mood swings 
 Women with underlying depression often feel 
better during or after menstruation, but their symptoms 
do not resolve completely. On the other hand, women with 
PMS or PMDD have a complete resolution of symptoms 
when menstruation phase begins[21]. 
Role of Ayurveda in PMS 
PMS remains as enigma because of the wide 
ranging symptoms and the difficulty in making a firm 
diagnosis. There are several theories which have been 
postulated to explain the cause of PMS but till today, no 
one has been proven. Secondarily, specific treatment for 
PMS still largely lacks a solid scientific basis. Widespread 
recognition of PMS has attracted a broad range of research 
interest in the treatment and management of the diverse 
symptoms of PMS. So Ayurveda can be considered as a 
boon in this challenging disease. Pacification of somatic 
symptoms along with improvement of psychomotor aspect 
of disease makes Ayurveda to be preferred choice in PMS.  
Avarana 
Concept of Avarana is one of the least understood 
concept among all fundamental principles of Ayurveda. 
According to Ayurvediya Shabdakosha, the word Avarana 
means Avarodha, Gatirodha i.e. obstruction in the normal 
Gati of Vata. Vata, which is strongest of all three Doshas, 
has Laghu, Ruksha, Sheeta, Chala, Vishada, Khara etc. Guna. 
It is due to Chala guna of Vata which is responsible for all 
the movements. If the Gati of Vata becomes obstructed, its 
functions will get hampered. Acharya Sushruta quoted 
three pathological conditions of Vata. 
Kevala vata 
Dosha yukta vata 
Avritta vata 
In case of Avarana, there are 2 components-one is 
Avaraka dosha which cause the Avarana or obstruction 
after getting vitiated, and other component is Avritta dosha 
which is getting Avritta or obstructed by Avaraka dosha 
and whose functions get affected by the obstruction. The 
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symptoms produced are based on the principle of Karma 
Vridhhi or Karma hani of Avritta dosha and secondarily the 
location of Dosha dushya sammourchhana. When there is 
complete obstruction or Avarana, Karam hani will be seen 
and when there is partial obstruction, Karma of the Avritta 
dosha gets vitiated so Karma vridhhi will be observed[22]. 
Simultaneously, the symptoms of Avritta dosha may occur 
in any part of body depending upon the site of Dosha 
dushya sammourchhana. e.g. when we consider Pittavritta 
Vyana Vayu, when there is Purna avarana of Pitta to Vyana 
Vayu, Gatra sanga will be there and when Anshika avarana, 
Gatra vikshepa will be seen. As the Sthana or location of 
Vyana Vayu is Sarva Sharira so Avarana of Pitta to Vyana 
Vayu may take place anywhere in all over the body, 
depending upon Srotas- Khavaigunyata and accordingly 
treatment is done.  
PMS in Ayurveda 
According to Ayurvedic concept, the health of an 
individual is attributed to the status of Doshas in his body. 
The balanced state of Doshas is the cause of health while an 
imbalance of Doshas is termed as disease. In Ayurveda, 
there is no clear cut evidence of disease Premenstrual 
Syndrome so it is difficult to give the disease a single 
Ayurvedic term. It can be correlated with different entities 
which one explained either as symptoms or disease. 
According to Acharya Charaka, in Charaka 
Sutrasthana 18/44, it is impossible to give the name to all 
the diseases so a learned physician should recognize the 
balanced or imbalanced state of Doshas in body and then 
treatment should be initiated after deciding the nature of 
disease. Taking all this into consideration, Ayurvedic 
concept of PMS has been made. 
Symptoms of the Disease PMS is seen few days 
prior to menstruation in luteal phase which can be 
mentioned as Rituvyateetakala in Ayurvedic terminology. 
As in Ayurvedic concept of menstruation, Artava or Ritu 
Chakra is classified as Ritukala, Rituvyateetakala and 
Rajakala. There is a specific pattern of Dosha dominance 
during these three Kala[23]. During Rituvyateetakala, there 
is dominance or Kopa of Pitta Dosha with Vata 
Sanchayavastha.  
Phase Ritukala Rituvyateetakala Rajahkala 
Dosha 
sanchaya 
Pitta Vata Kapha 
Dosha 
Prakopa 
Kapha Pitta Vata 
Dosha 
shamana 
Vata Kapha Pitta 
Symptoms of Pittavritta Vyana Vayu as mentioned 
by Acharya Charaka are. 
Daha Sarvanga  
Klama 
Gatra vikshepa sanga 
Santapa 
Vedana 
 In Rituvyateetakala, already Pitta remains in 
Kupitavastha; and when Pittavardhaka nidan sevana is 
done by any women specifically during this Kala, there is 
exponentially rise in Pitta quantitatively. This excessive 
Kupita Pitta blocks the normal path of Vata specifically 
Vyana Vata. Vyan vayu is responsible for all Gati, 
Prasarana, Aakunchana, Utkshepa, Avakshepa, Nimesh 
unmesha adi kriya, leading to manifestations of Pittavritta 
Vyana vayu like Sarvanga daha, Klama etc., Thus Both Pitta 
and Vyana vayu in turn leads to Avaraka and Avritta 
components of Avarana respectively. As the 
Rituvyateetakala ends and Rajahkala begins; Pitta, which is 
in aggravated state and was acting as Avaraka dosha, 
automatically comes back to its Shaman state so pacifies 
the symptoms of Pittavritta Vyana Vayu or PMS. 
Simultaneously, in PMS or PMDD, due to genetic 
predisposition, risk factors like cigarette smoking, stress, 
junk food (which is common in today’s working women), 
there in imbalance of various hormones including estrogen 
and progesterone. This cyclical fluctuation in circulating 
estrogen and progesterone cause marked change in neuro-
transmitters like Opioid[24], GABA[25] and serotonin[26] 
system which manifests in the form of PMS. 
 
Pittavritta Vyana Vayu                      PMS, PMDD  
Pittavardhaka ahara, Vihara    Genetic predisposition, stress, risk 
(spec. in Rituvyateetakala)    factors like cigarette smoking, junk food 
 
 
Pitta prakupita avastha      Imbalance of various hormones like  
        Estrogen and progesterone 
     
Hamper the normal Gati of Vata,     
         Cause marked change in 
Acts as Avaraka Dosha      neurotransmitters like GABA, serotonin 
  
 
Termed as Pitta avritta Vyana Vayu          Manifests as PMS,PMDD 
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Table 1: Symptoms of PMS in correlation to Pittavritta Vyana Vayu 
Pittavritta vyanavayu Premenstrual syndrome 
Sarvanga Daha Hot flushes 
Klama Exhaustion, tiredness without any work 
Gatra vikshepa sanga Luteal pattern of Catamenial epilepsy (seizure exacerbation that 
aligns with luteal phase of menstrual cycle (usually not in PMS) 
Santapa -Deha, Indriya manas Raised temperature of body 
Mood and behavioral disorders irritability, anxiety, emotional up 
Vedana Cramps in abdomen, Pain in breast, generalized aches 
  
Pittavritta Vyana Vayu can be managed on the line 
of Avarana Chikitsa. Acharya Charaka has mentioned the 
treatment of Pittavritta Vyana Vayu in Vatavyadhi 
Chikitsadhyaya. Nidana Parivarjan, the 1st line of treatment 
should be done by avoiding Pittavardhaka ahara, Vihara. 
The management of Avarana should aim towards cleansing 
the Srotas with different medications, Vatanulomana[27] 
along with Panchkarma therapy. The selection of specific 
Panchkarma is done to remove of Avaraka Dosha, i.e. Pitta. 
So when Pitta is obstructing Vyana Vayu, then Pitta 
Avarana removal management should be done. Virechana 
with Eranda taila can be a choice of drug in this disease. 
Depending upon the Anupana, Eranda Taila removes 
various Avarana e.g. when administered with Mansa rasa 
and Yusha, it mitigates Vata, when administered with milk, 
mitigates Pitta and when it is administered with Gomutra, 
it mitigates Avarana of Kapha dosha. So in all type of 
Avarana, Eranda taila can be used accordingly. Yapana 
Basti can be given as it is choice of treatment in majority of 
Avarana due to its Tridoshahara property. It can be given 
at any time, in any season and is devoid of any 
complication. Other than this, Manjisthadi ksheera Basti, 
Madhuyasthi ksheera Basti, Guduchyadi ksheera Basti, 
Pichha Basti may be considered for the management. In 
Nasya chikitsa, Ksheera nasya can be administered. Besides 
this, other Panchkarma procedures can be used depending 
upon the location of Doshadushya sammourchhana. 
Rasayana drugs with Madhura rasa (which pacifies Vata as 
well as Pitta) e.g. Bala, Goghrita, Shatavari, Draksha, 
Kharjoor, Madhuyasthi, Madhura Trifla can be used 
internally. Yogic exercises like Pranayama, Bhramri, 
Sheetali etc. can be practiced to reduce the psychosomatic 
manifestation of the disease.  
CONCLUSION 
Throughout most of the history, there has been a 
certain amount of taboo involved in the discussion of the 
female menstrual cycle. During the cycle, hormonal 
fluctuation happens within the body which may lead to 
various annoying symptoms. This recurrent complex of 
physical, psychological and behavioral symptoms which is 
termed as Premenstrual Syndrome, affects large 
population of females. Many of them do not like to disclose 
such complaints to anybody due to which several of them 
left undiagnosed and if left untreated, it affects her social 
life as well as family life. So they should be diagnosed and 
treated properly. PMS is not known by a single name in 
Ayurveda so according to its symptoms and phase of 
occurrence of symptoms, the disease can be related to 
Pittavritta Vyana Vata. Though an effective cause and so 
the effective treatment has not yet been found for PMS in 
Modern Medicine, Ayurveda can offer a great benefit to the 
female population by improving her psychosocial as well 
as physical health which ultimately contributes to a 
healthy society.  
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